| Kelly M Young, RN, CNP | |
|
1009 Ridgeway Pl, Farmington, NM 87401-2092 | |
| (505) 327-0002 | |
| (505) 325-9443 |
| Full Name | Kelly M Young |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 9 Years |
| Location | 1009 Ridgeway Pl, Farmington, New Mexico |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1245679000 | NPI | - | NPPES |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| San Juan Health And Wellness Center Llc | 4284905308 | 5 |
News Archive
The patent covers a novel technique for the integration of nanofluidic channels with sample delivery systems, enabling single molecules of DNA, RNA or other proteins to be separated out from standard laboratory samples for direct imaging and analysis.
"In an age of austerity, when everyone is feeling the pinch, some question whether we should continue giving aid to poor countries," Justin Forsyth, CEO of Save the Children U.K., writes in a Telegraph opinion piece.
Sporting events can bring a community together, such as when the Louisville Cardinals won the NCAA championship and University of Louisville campus was filled with camaraderie.
RXi Pharmaceuticals Corporation, a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), announced today that it has entered into a research collaboration with Mirna Therapeutics (Austin, TX), to determine the utility of combining RXi's proprietary rxRNA™ technology with Mirna's microRNA mimics as potential therapeutics in oncology. The parties will each contribute technology and resources to the collaboration to generate and evaluate novel microRNA compounds.
Bolstering the notion that RNA should be considered an important drug-discovery target, scientists at Scripps Research have found that several existing, FDA-approved anti-cancer drugs may work, in part, by binding tightly to RNA, the regulators of the basic activities of life within cells.
› Verified 4 days ago
| Entity Name | San Juan Health And Wellness Center Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568998029 PECOS PAC ID: 4284905308 Enrollment ID: O20170809000144 |
News Archive
The patent covers a novel technique for the integration of nanofluidic channels with sample delivery systems, enabling single molecules of DNA, RNA or other proteins to be separated out from standard laboratory samples for direct imaging and analysis.
"In an age of austerity, when everyone is feeling the pinch, some question whether we should continue giving aid to poor countries," Justin Forsyth, CEO of Save the Children U.K., writes in a Telegraph opinion piece.
Sporting events can bring a community together, such as when the Louisville Cardinals won the NCAA championship and University of Louisville campus was filled with camaraderie.
RXi Pharmaceuticals Corporation, a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), announced today that it has entered into a research collaboration with Mirna Therapeutics (Austin, TX), to determine the utility of combining RXi's proprietary rxRNA™ technology with Mirna's microRNA mimics as potential therapeutics in oncology. The parties will each contribute technology and resources to the collaboration to generate and evaluate novel microRNA compounds.
Bolstering the notion that RNA should be considered an important drug-discovery target, scientists at Scripps Research have found that several existing, FDA-approved anti-cancer drugs may work, in part, by binding tightly to RNA, the regulators of the basic activities of life within cells.
› Verified 4 days ago
| Entity Name | Ideal Option Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457788275 PECOS PAC ID: 6709013105 Enrollment ID: O20200226002684 |
News Archive
The patent covers a novel technique for the integration of nanofluidic channels with sample delivery systems, enabling single molecules of DNA, RNA or other proteins to be separated out from standard laboratory samples for direct imaging and analysis.
"In an age of austerity, when everyone is feeling the pinch, some question whether we should continue giving aid to poor countries," Justin Forsyth, CEO of Save the Children U.K., writes in a Telegraph opinion piece.
Sporting events can bring a community together, such as when the Louisville Cardinals won the NCAA championship and University of Louisville campus was filled with camaraderie.
RXi Pharmaceuticals Corporation, a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), announced today that it has entered into a research collaboration with Mirna Therapeutics (Austin, TX), to determine the utility of combining RXi's proprietary rxRNA™ technology with Mirna's microRNA mimics as potential therapeutics in oncology. The parties will each contribute technology and resources to the collaboration to generate and evaluate novel microRNA compounds.
Bolstering the notion that RNA should be considered an important drug-discovery target, scientists at Scripps Research have found that several existing, FDA-approved anti-cancer drugs may work, in part, by binding tightly to RNA, the regulators of the basic activities of life within cells.
› Verified 4 days ago
| Entity Name | Ideal Telemedicine Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346754868 PECOS PAC ID: 2860726221 Enrollment ID: O20200406000172 |
News Archive
The patent covers a novel technique for the integration of nanofluidic channels with sample delivery systems, enabling single molecules of DNA, RNA or other proteins to be separated out from standard laboratory samples for direct imaging and analysis.
"In an age of austerity, when everyone is feeling the pinch, some question whether we should continue giving aid to poor countries," Justin Forsyth, CEO of Save the Children U.K., writes in a Telegraph opinion piece.
Sporting events can bring a community together, such as when the Louisville Cardinals won the NCAA championship and University of Louisville campus was filled with camaraderie.
RXi Pharmaceuticals Corporation, a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), announced today that it has entered into a research collaboration with Mirna Therapeutics (Austin, TX), to determine the utility of combining RXi's proprietary rxRNA™ technology with Mirna's microRNA mimics as potential therapeutics in oncology. The parties will each contribute technology and resources to the collaboration to generate and evaluate novel microRNA compounds.
Bolstering the notion that RNA should be considered an important drug-discovery target, scientists at Scripps Research have found that several existing, FDA-approved anti-cancer drugs may work, in part, by binding tightly to RNA, the regulators of the basic activities of life within cells.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kelly M Young, RN, CNP 1009 Ridgeway Pl, Farmington, NM 87401-2092 Ph: () - | Kelly M Young, RN, CNP 1009 Ridgeway Pl, Farmington, NM 87401-2092 Ph: (505) 327-0002 |
News Archive
The patent covers a novel technique for the integration of nanofluidic channels with sample delivery systems, enabling single molecules of DNA, RNA or other proteins to be separated out from standard laboratory samples for direct imaging and analysis.
"In an age of austerity, when everyone is feeling the pinch, some question whether we should continue giving aid to poor countries," Justin Forsyth, CEO of Save the Children U.K., writes in a Telegraph opinion piece.
Sporting events can bring a community together, such as when the Louisville Cardinals won the NCAA championship and University of Louisville campus was filled with camaraderie.
RXi Pharmaceuticals Corporation, a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), announced today that it has entered into a research collaboration with Mirna Therapeutics (Austin, TX), to determine the utility of combining RXi's proprietary rxRNA™ technology with Mirna's microRNA mimics as potential therapeutics in oncology. The parties will each contribute technology and resources to the collaboration to generate and evaluate novel microRNA compounds.
Bolstering the notion that RNA should be considered an important drug-discovery target, scientists at Scripps Research have found that several existing, FDA-approved anti-cancer drugs may work, in part, by binding tightly to RNA, the regulators of the basic activities of life within cells.
› Verified 4 days ago
Erin Tinker, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 407 S Schwartz Ave Ste 102, Farmington, NM 87401 Phone: 505-609-6700 Fax: 505-609-6700 | |
Jennifer Lizabeth Manganello, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 407 S Schwartz Ave, Suite 101, Farmington, NM 87401 Phone: 505-609-6770 Fax: 505-609-6775 | |
Anariza Grush, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1001 W Broadway, Farmington, NM 87401 Phone: 505-327-4796 | |
Bethany Lynn Jones, AGPNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1001 W Broadway, Farmington, NM 87401 Phone: 505-327-4796 Fax: 505-599-9351 | |
Jovite A Larroy, CNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1001 W Broadway Ste E, Farmington, NM 87401 Phone: 505-327-4796 | |
Clay Church, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 801 W Maple St, Farmington, NM 87401 Phone: 505-609-2000 | |
Ms. Mois A Johnson, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 203 W Main St, Farmington, NM 87401 Phone: 505-517-4181 Fax: 505-333-0444 |